Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Authlogics Ltd

10 Oct 2022 07:01

RNS Number : 2583C
Intercede Group PLC
10 October 2022
 

 Intercede Group PLC

("Intercede," "the Company" or the "Group'') 

Acquisition of Authlogics Ltd

Gives Intercede capability to address the whole authentication pyramid and increases addressable market by 10x

Intercede Group PLC (AIM: IGP), a leading supplier of Public Key Infrastructure Credential Management Software, is pleased to announce the acquisition of Authlogics Ltd ("Authlogics", the Acquisition"), a Multi Factor Authentication ('MFA') and Password Security Management ('PSM') software vendor, for initial consideration of £2.5 million (adjusted to approximately £2.0 million after net debt and working capital adjustments) plus a further deferred conditional and staged earnout payment of up to £3 million.

Acquisition highlights

· Strong strategic rationale: acquiring IP that will significantly expand Intercede's addressable market

· Accelerates Intercede's ability to meet the requirements of new regulatory standards

· Authlogics run rate recurring annual revenue of £0.5m further enhances Intercede's ARR

· Initial consideration will be satisfied using Intercede's existing cash resources

· Acquisition expected to be earnings enhancing in the financial year commencing 1 April 2023

· As also announced today, Intercede is trading in line with management expectations

Klaas van der Leest, CEO of Intercede Group, commented:

"The acquisition of Authlogics enables us to deliver on the strategic vision that we have shared with investors of addressing the entire authentication pyramid. We believe that the addition of the Authlogics products will allow us to support our customers and prospects wherever they are in their authentication journey, and to embrace a wider set of use cases. The deal also increases our recurring revenue base.

We are delighted to welcome the Authlogics team to the Group, along with their customers, partners and distributors."

FURTHER INFORMATION ON THE ACQUISITION 

Background To Authlogics

Authlogics is a UK headquartered business based in Bracknell and was founded in June 2015. A Multi Factor Authentication ('MFA') and Password Security Management ('PSM') software vendor, Authlogics is the only business to cover all three key authentication segments (password security management, password breach database and multi factor authentication) with a seamless integrated solution. The Company's award-winning products service over 50 customers with 44 annual recurring software contracts across the Finance, Government, Defence and Healthcare sectors.

Authlogics primarily sells into the Middle East through a blue-chip global partner network. Authlogics has a high degree of recurring revenue (more than 95%) and is expected to grow strongly over the next three years.

Authlogics revenue grew at a 61% compound rate between the financial years ending 30 June 2018 and the 30 June 2021. In the year ended 30 June 2021, Authlogics made a small profit after tax of £8,000.

Whilst the Acquisition is primarily an IP deal, Authlogics had £0.5m of annual recurring revenue ("ARR") as at 30 June 2022.

Strategic Rationale

Passwords remain pervasive throughout the cybersecurity market, despite the majority of data breaches arising due to compromised password credentials. Intercede has set out its strategic objective of supporting customers wherever they are on their passwordless journey by broadening the footprint across the authentication pyramid beyond our current position in the Public Key Infrastructure Credential Management System ('PKI CMS') segment.

During this calendar year, the strategic rationale has sharpened following the introduction of new regulatory standards (e.g. FIPS 201-3) in our core US federal and defence markets. These new regulations allow customers and prospects in these markets to begin to adopt technologies beyond PKI. The addition of the Authlogics products will, in a single step, allow us to address the entire authentication pyramid. This enlarges our addressable market more than 10-fold, and these markets are predicated to grow significantly over the next three years. We believe this enhanced combination ranging from Passwords to PKI will give Intercede a significant competitive advantage.

Furthermore, the PKI segment is complex and involves long sales and integration cycles. The MFA and PSM markets are characterised by simpler sales and integration cycles which should help with the Group's revenue visibility going forward. Authlogics provides exposure to markets outside of Europe which are less penetrated and provide Intercede with the opportunity to grow its international footprint and deliver increased revenue growth over time.

The Acquisition creates a broader product portfolio for Intercede. This portfolio is expected to grow to cover Single Sign On (SSO) and Ongoing Authorisation products which will further enhance Intercedes' client offering.

Acquisition terms

Four of the current Authlogics staff will become Intercede employees, including the two Authlogics founders.

Under the terms of the Acquisition, Intercede will pay:

· Initial consideration of £2.5 million on a debt free/cash free basis; plus

· further deferred conditional and staged earnout payment of up to £3 million.

The deferred consideration is subject to achievement of significant revenue growth targets on sales of Authlogics products by the enlarged Group in the three years to 30 June 2025. The initial consideration of £2.5 million before adjustments for net debt and working capital movement, will be satisfied using the Group's existing cash resources. The non-contingent multiple on the initial consideration is 5x ARR as at 30 June 2022.

The Intercede Board believe that the acquisition will be earnings accretive in the financial year commencing 1 April 2023.

 

 

 

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

finnCap Ltd

Tel. + 44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan

Corporate Finance

Tim Redfern/Charlotte Sutcliffe

ECM

 

For more information visit: www.intercede.com

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

Our vision is to make the highest levels of cybersecurity available to organisations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUPGPWUUPPGBB
Date   Source Headline
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.